FDA NCTR Summer 2025 Student Research Participation Program

Overview

Applications will be reviewed on a rolling-basis.

FDA Office and Location: Summer research opportunities are available at the National Center for Toxicological Research (NCTR), U.S. Food and Drug Administration (FDA) in Jefferson, Arkansas. Selected individuals will train alongside NCTR investigators who conduct FDA mission-critical, translational research that provides a scientifically sound basis for FDA regulatory decisions, and that reduces risks associated with FDA-regulated products. For additional information about this opportunity, NCTR or FDA, please visit www.FDA.gov.

Anticipated Appointment Start Date: May 27th, 2025 and end date August 1st, 2025.  Start date is flexible and will depend on a variety of factors.

Appointment Length: The appointment will initially be for ten weeks, but may be renewed upon recommendation of FDA and is contingent on the availability of funds.

Level of Participation: The appointment is full time.

Citizenship Requirements: This opportunity is available to U.S. citizens only.

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Completion of a successful background investigation by the Office of Personnel Management is required for an applicant to be on-boarded at FDA.  OPM can complete a background investigation only for individuals, including non-US Citizens, who have resided in the US for a total of three of the past five years.

FDA Ethics Requirements

If an ORISE Fellow, to include their spouse and minor children, reports what is identified as a Significantly Regulated Organization (SRO) or prohibited investment fund financial interest in any amount, or a relationship with an SRO, except for spousal employment with an SRO, and the individual will not voluntarily divest the financial interest or terminate the relationship, then the individual is not placed at FDA. For additional requirements, see FDA Ethics for Nonemployee Scientists.

FDA requires ORISE participants to read and sign their FDA Education and Training Agreement within 30 days of his/her start date, setting forth the conditions and expectations for his/her educational appointment at the agency.  This agreement covers such topics as the following:

Non-employee nature of the ORISE appointment;
Prohibition on ORISE Fellows performing inherently governmental functions;
Obligation of ORISE Fellows to convey all necessary rights to the FDA regarding intellectual property conceived or first reduced to practice during their fellowship;
The fact that research materials and laboratory notebooks are the property of the FDA;
ORISE fellow’s obligation to protect and not to further disclose or use non-public information.
Qualifications
The qualified candidate should be currently pursuing or have received an associate’s, bachelor’s, master’s, or doctoral degree in the one of the relevant fields.

Applicants must be U.S. citizens and at least 18 years of age at the time of the appointment. Applicants must be a student in good standing at an accredited U.S. college or university, or accepted as an entering graduate or professional student at an accredited college or university, with a cumulative GPA of 2.50 or higher (based on a 4.0 scale).